Drugs submitted for FDA approval must have safety and efficacy data for the condition they're designed to treat. Sometimes, however, a drug is found to be effective for another condition, and doctors are within their rights to prescribe it for such "off-label" uses. Such may soon be the case for metformin.
A new study offers hope for finding a better treatment for preeclampsia, a condition that claims 100 mothers everyday worldwide.
Last November we commented on a rather startling development in the treatment of type 2 diabetes. A widely-used family of drugs called sulfonylureas (Avandia and Glipizide, for 2 examples) was found to increase heart attacks, strokes and death by about 20 percent